Come on over to the MOGN BB board. MGI Pharma has a cytotoxin MGI-114 in various Phase II trials. We are interested in discussion and want to be level-setted where possible. We have various representation from financial, investor, and even a person who helped develop MGI-114 at UCSD on board. We are lite on oncologist. You would be welcomed here.